Simplicity Wealth LLC Trims Stock Position in Astera Labs, Inc. $ALAB

Simplicity Wealth LLC trimmed its holdings in Astera Labs, Inc. (NASDAQ:ALAB) by 11.7% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 10,750 shares of the company’s stock after selling 1,425 shares during the period. Simplicity Wealth LLC’s holdings in Astera Labs were worth $1,178,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently modified their holdings of ALAB. Reflection Asset Management purchased a new position in shares of Astera Labs during the 4th quarter worth about $25,000. Smartleaf Asset Management LLC grew its holdings in Astera Labs by 422.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock valued at $32,000 after purchasing an additional 152 shares during the period. Hilltop National Bank increased its position in Astera Labs by 100.0% during the fourth quarter. Hilltop National Bank now owns 200 shares of the company’s stock worth $33,000 after purchasing an additional 100 shares during the last quarter. Aventura Private Wealth LLC acquired a new position in Astera Labs during the fourth quarter worth approximately $33,000. Finally, Towarzystwo Funduszy Inwestycyjnych PZU SA purchased a new position in Astera Labs during the fourth quarter worth approximately $33,000. Institutional investors and hedge funds own 60.47% of the company’s stock.

Analyst Upgrades and Downgrades

ALAB has been the topic of a number of research analyst reports. Needham & Company LLC lifted their price target on shares of Astera Labs from $220.00 to $260.00 and gave the company a “buy” rating in a report on Wednesday, May 6th. Bank of America upped their price objective on Astera Labs from $240.00 to $450.00 and gave the stock a “neutral” rating in a report on Tuesday, June 23rd. Citigroup lowered Astera Labs from a “buy” rating to a “market perform” rating in a research report on Tuesday, May 26th. Barclays lifted their target price on Astera Labs from $165.00 to $200.00 and gave the company an “equal weight” rating in a report on Thursday, May 7th. Finally, Rothschild & Co Redburn started coverage on Astera Labs in a research note on Friday, May 1st. They set a “neutral” rating and a $153.00 price target for the company. Twelve research analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $265.75.

Insider Activity

In other Astera Labs news, CEO Jitendra Mohan sold 325,693 shares of the company’s stock in a transaction dated Friday, April 17th. The shares were sold at an average price of $172.14, for a total value of $56,064,793.02. Following the completion of the transaction, the chief executive officer directly owned 4,079,322 shares of the company’s stock, valued at $702,214,489.08. This represents a 7.39% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Manuel Alba sold 136,974 shares of the firm’s stock in a transaction dated Wednesday, July 1st. The shares were sold at an average price of $442.01, for a total value of $60,543,877.74. Following the sale, the director owned 1,287,524 shares of the company’s stock, valued at $569,098,483.24. This represents a 9.62% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders sold 2,040,691 shares of company stock worth $507,675,380. 10.40% of the stock is currently owned by company insiders.

Astera Labs Stock Performance

Astera Labs stock opened at $412.97 on Monday. The firm has a market capitalization of $70.79 billion, a PE ratio of 279.03, a price-to-earnings-growth ratio of 4.65 and a beta of 3.66. Astera Labs, Inc. has a one year low of $88.18 and a one year high of $499.48. The stock’s 50 day moving average price is $335.76 and its 200 day moving average price is $214.94.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.54 by $0.07. The company had revenue of $308.36 million during the quarter, compared to the consensus estimate of $292.19 million. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. Astera Labs’s revenue for the quarter was up 93.5% on a year-over-year basis. During the same quarter last year, the company earned $0.33 earnings per share. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, analysts forecast that Astera Labs, Inc. will post 1.88 earnings per share for the current fiscal year.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.